(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Breaking: IonQ Sees Record Bookings, Beyond Air Q4 Disappoints, Nuvve Unveils Astrea AI

June 23rd, 2023

Shares of IonQ, Inc. (NYSE: IONQ) surged over 5% in after-hours trading following an announcement of increased 2023 bookings expectations.  The company has revised its range from $38 million to $42 million to a new range of $45 million to $55. Read more

ROV Discovery: Tail Section of Titan Submersible Located near Titanic

June 23rd, 2023

In the ongoing search for the missing submersible, Titan, near the Titanic wreckage site, the Unified Command has made significant progress. A debris field has been located approximately 1,600 feet off the bow of the Titanic, thanks to the efforts. Read more

Russell Indexes Boost CMPX and CVRX; EOSE, ITUB, KBH, SOUN, and FLNC Gain PT Boosts

June 23rd, 2023

Compass Therapeutics, Inc. (Nasdaq: CMPX), a biotechnology company focused on the development of antibody therapeutics, and CVRx, Inc. (Nasdaq: CVRX), a medical device company specializing in neuromodulation therapies, have both announced their inclu. Read more

Citigroup's Perspective: Upside Potential for EXAS, MNDY, WK, and BSX Revealed

June 22nd, 2023

Exact Sciences Corporation (Nasdaq: EXAS), a prominent healthcare company specializing in molecular diagnostics, has been maintained at a Buy rating by Citigroup, who raised the price target from $100 to $130. Despite $EXAS closing at $95.05 on Th. Read more

Breaking: Trupanion Surges on Rate Filing Outcome; FDA Rebuffs Intercept's NASH-related NDA

June 22nd, 2023

Shares of Trupanion, Inc. (Nasdaq: TRUP) experienced a significant surge of over 10% in after-hours trading as the company revealed positive updates on its rate filing approval status in California and New York. The company received approvals for . Read more

Key Analyst Ratings: PBA, CELH, ASM, EQIX, MKSI, and NDSN - Latest Updates

June 22nd, 2023

Pembina Pipeline Corporation (NYSE: PBA), a leading energy infrastructure company, received a favorable coverage initiation from Stifel with a Buy rating and a price target of $51.  Despite $PBA closing at $30.96 on Wednesday, the investment . Read more

Earnings Reaction Rollercoaster: Darden Restaurants Dips, FactSet Rises

June 22nd, 2023

Darden Restaurants, Inc. (NYSE: DRI) delivered solid financial results for the fourth quarter of fiscal 2023.  While the earnings per share (EPS) of $2.58 slightly surpassed the consensus estimate of $2.54, the company reported quarterly sale. Read more

Market Shakers: GMS, T2 Biosystems, Tesla, and Palantir Make Waves

June 22nd, 2023

GMS Inc. (NYSE: GMS) announced its fourth-quarter fiscal 2023 results, surpassing expectations with an adjusted EPS of $2.11 compared to the consensus estimate of $1.89. The company reported quarterly sales of $1.30 billion, exceeding the consensus r. Read more

The Hunt for Titan: Extensive Search Efforts for Missing Submersible

June 22nd, 2023

The search for the missing submersible, Titan, continues as multiple assets and organizations join forces in the effort. The Canadian Coast Guard, equipped with sonar capabilities, has been actively involved since Wednesday, supported by commercial v. Read more

Avid Bioservices Q4 Falls Short; SNA, STZ, WCC, TYL, AVTR, SRDX: Analysts Eye Opportunity

June 22nd, 2023

Avid Bioservices, Inc. (Nasdaq: CDMO) reported a net loss of approximately $0.3 million for the fourth quarter of fiscal 2023, which fell short of the consensus estimate of breakeven. Looking ahead to fiscal 2024, the company anticipates revenue i. Read more